Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study - sprookjes - yvandenbroek - TriplyDB

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

http://www.wikidata.org/entity/Q30491056

about

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association Dietary factors and incident atrial fibrillation: the Framingham Heart Study Biomarkers and the prediction of atrial fibrillation: state of the art How to Develop, Validate, and Compare Clinical Prediction Models Involving Radiological Parameters: Study Design and Statistical Methods European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate Diagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the Solution to This Elusive Arrhythmia?Emerging directions in the genetics of atrial fibrillation Clinical prediction rules in practice: review of clinical guidelines and survey of GPs Cardiac target organ damage in hypertension: insights from epidemiology NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?P-wave dispersion: an update Evaluating the benefits of home-based management of atrial fibrillation: current perspectives The Associations between Various Ectopic Visceral Adiposity and Body Surface Electrocardiographic Alterations: Potential Differences between Local and Remote Systemic Effects Heart disease and stroke statistics--2014 update: a report from the American Heart Association Heart disease and stroke statistics--2012 update: a report from the American Heart Association Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.High-Sensitivity Troponin as a Biomarker in Heart Rhythm Disease.Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association A common SCN5A variant is associated with PR interval and atrial fibrillation among African Americans EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Use of computed tomography to identify atrial fibrillation associated differences in left atrial wall thickness and density.American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.Infiltrated atrial fat characterizes underlying atrial fibrillation substrate in patients at risk as defined by the ARIC atrial fibrillation risk score Clinical outcome as a function of the PR-interval-there is virtue in moderation: data from the Duke Databank for cardiovascular disease.Distinct risk factors of atrial fibrillation in patients with and without coronary artery disease: a cross-sectional analysis of the BOREAS-CAG Registry data.Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study.Digital Connectedness in the Framingham Heart Study.Diagnostic Performance of a Smartphone-Based Photoplethysmographic Application for Atrial Fibrillation Screening in a Primary Care Setting.Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram.Lone atrial fibrillation: does it exist?Statistical evaluation of adding multiple risk factors improves Framingham stroke risk score Relation of Obstructive Sleep Apnea and a Common Variant at Chromosome 4q25 to Atrial Fibrillation.Short-term repeatability of electrocardiographic P wave indices and PR interval Longitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community.Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study.Modern role for clopidogrel in management of atrial fibrillation and stroke reduction Assessing the incremental predictive performance of novel biomarkers over standard predictors.Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants.

P2860

Q22306356-37C75D83-6D8E-4C58-8A9A-CB45DFC4D3F9 Q24597276-BBDED610-A54C-46F0-B68D-48F532DB1F8F Q26739847-3CD26C3F-F984-4437-B6FD-B8C15084E18F Q26748660-F861764D-75C7-4554-9839-45C57902ACD0 Q26796261-37EA3A88-C6C0-41D7-8E70-CA6366F15861 Q26799163-722ECA65-46A7-44DB-9AFE-ADF2A72A517E Q26800991-E09B2E2B-AFD1-4130-A058-2A281CB86D78 Q26852051-8A8330E9-6872-4FDE-9A9B-3C6BDBCAB180 Q27002373-9B9F0E29-B6F0-4789-91F9-3A60D37B976A Q27007701-CD7013A6-DFDD-4438-9621-CD62CE22658E Q28072348-1FACF830-263C-41AE-9DC5-359BB7CB0A53 Q28074040-E4EEF31C-70AF-4203-8422-C0A83019F5FC Q28079137-A596C713-976E-4021-9F53-5BC03E9B2143 Q28552513-A6CB6757-F144-4B79-A469-83685E550470 Q29547691-4BDAAF50-1D01-4E28-A06C-69419B88C19F Q29547909-3266D83F-0406-46FC-9A12-DB5BAA0BEC0B Q30234626-14903276-5B8E-4209-8691-140667186790 Q30235455-C2903D6D-A572-4715-A48A-01C31135B361 Q30238784-5190B7B3-1149-487D-9764-B97AE0D015D7 Q30370146-FFE4D7ED-D8F9-493A-8E15-642796071535 Q30375302-B741AA7C-7E64-478E-B276-B800AC860A03 Q30415564-C4D046CD-B3F4-41B6-A742-F94A17EBE86A Q30425918-5151D902-9614-47D1-A1B4-A8FCDFF6F48A Q30663685-9A0328B0-34F9-49D6-9762-CAD89622AFC2 Q30746515-76CCED6E-3F98-404B-9145-0A1B9DF11E4D Q30845439-63F683DE-26BC-49EB-B39A-5AE6C95D4AD6 Q31156918-F89D8B02-DB67-4459-9A5B-9122A725B121 Q31160340-A8BC7438-6011-408A-989F-A522AE75586D Q33448211-8A5585F4-7295-46BB-B8F8-D3D77D5CB6A4 Q33449798-3BD253EB-A2DF-4FEC-A40B-3FF39DAC9784 Q33451086-676890BF-F69D-4A94-AA37-FD8430AA043C Q33560948-0AF88F2D-E1A9-4C5E-8523-8248786FEB7F Q33564681-F269F896-0413-43CD-9551-9ACF8ABBC6C9 Q33566207-08340DD1-33B8-43BC-BF36-C5BE2445591F Q33642264-8DA23463-06F8-43C5-A760-6E94ACF370E2 Q33659377-D71B262A-D9F9-43D2-9D54-FE39B5957A19 Q33668906-8E709569-0171-4D46-92D6-EA4DC0D424AE Q33715413-C3B4FD0F-1E3A-4CF2-B066-6D9CB1720577 Q33717407-C9C7EE1F-3328-4861-B4D0-1B321C744AC0 Q33721705-80B45FB2-D2DF-49C5-AE1B-B6F586B018DF

P2860

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

http://www.wikidata.org/entity/Q30491056

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Development of a risk score fo ...... a community-based cohort study

@ast

Development of a risk score fo ...... a community-based cohort study

@en

type

label

Development of a risk score fo ...... a community-based cohort study

@ast

Development of a risk score fo ...... a community-based cohort study

@en

prefLabel

Development of a risk score fo ...... a community-based cohort study

@ast

Development of a risk score fo ...... a community-based cohort study

@en

P1433

Q30491056-9613CE76-77EB-4D72-8E15-44E04214DCF8

P1476

Q30491056-AB9B4A35-8097-4AFE-BC63-0D50CF593973

P2093

Q30491056-0226F9ED-E23E-4973-B73E-6DE3CFF86BE5

Q30491056-0976F423-D213-4B16-A8D6-87A9ED92AC03

Q30491056-34B660D1-13DA-4142-BD20-9A8C47B46C49

Q30491056-70AB0E07-B5B8-4EF0-88E0-64B60AB76959

Q30491056-8D71986B-BA25-4E9F-AF15-E7E6B95BE4BE

Q30491056-B3650F1D-8414-4E4C-8741-33348ABF83E6

Q30491056-BC8C4D01-225E-4A76-8AF4-8CB9E8B47082

Q30491056-BFC81CEE-78FF-4CF8-BCCE-0E823453FF78

Q30491056-C80B63B0-E4D2-455B-AE01-9AFFCAB534D4

P2860

Q30491056-083CD173-66CF-43ED-921E-A495DA8EB8BB

Q30491056-087D9477-151A-49F2-B59A-D6F806DED65A

Q30491056-0910AE5E-EBE0-459A-8649-21BB7F55347D

Q30491056-111D16BD-E442-4810-8361-13EDF26D6C1D

Q30491056-1D9B8A63-5F6C-4348-8572-A8FDF04C4A6F

Q30491056-277D4AAA-EF55-4506-A346-671EB3B1506A

Q30491056-44C7E083-4BFF-40C4-979D-5F304FDC6CCA

Q30491056-4E5E9136-AB8E-4A71-9EC4-374C27D9143E

Q30491056-537016F1-F160-4373-AE6C-DE7DB97003EA

Q30491056-67BBB080-0994-42F9-8CD7-B7C9150B03E5

P304

Q30491056-B12BF76B-AA4E-4807-959B-C4D1EF852F5F

P31

Q30491056-F35EA78E-1C35-4724-8C8D-68843ADE1234

P356

Q30491056-05955365-32E5-4502-9754-3DF9FCACC8B8

P407

Q30491056-6A07F44A-772C-490D-875D-48A082324BEF

P433

Q30491056-1813191C-D1D3-4130-BC76-4141C7EE5B06

P478

Q30491056-D13E7009-D647-4436-A21C-E58F9BB6E062

P50

Q30491056-43A836E4-F0B4-42C8-AA51-D6DDBED69F48

Q30491056-56C93B62-1152-4936-9A1B-36C1F6EBF7F8

Q30491056-5A58F051-3166-4C84-9234-0FEF07A51A38

Q30491056-86FA8393-949B-429A-B7DF-914974EE3575

Q30491056-8C377817-4F9F-404B-9C9D-F7108F261899

Q30491056-E4A88516-49C0-4567-9B2E-35F27B449048

Q30491056-F0F63192-6BA8-47CA-85D9-0DA2B771C131

P577

Q30491056-E17E5F47-048B-4119-812D-536BACB5EEAD

P698

Q30491056-2046CFEA-BEE8-4501-91DC-1714026F417D

P921

Q30491056-342DFCA9-696E-4032-BB27-FBA76DFF8DE5

P932

Q30491056-5EAE51EB-6CBF-4A90-91E4-8368B2CB3E9C

P356

S0140-6736(09)60443-8

P1433

P1476

Development of a risk score fo ...... a community-based cohort study

@en

P2093

Daniel Levy

http://www.w3.org/2001/XMLSchema#string

Jared W Magnani

http://www.w3.org/2001/XMLSchema#string

Jennifer F Yamamoto

http://www.w3.org/2001/XMLSchema#string

Patrick T Ellinor

http://www.w3.org/2001/XMLSchema#string

Ralph B D'Agostino

http://www.w3.org/2001/XMLSchema#string

Renate B Schnabel

http://www.w3.org/2001/XMLSchema#string

Thomas J Wang

http://www.w3.org/2001/XMLSchema#string

Thomas M Tadros

http://www.w3.org/2001/XMLSchema#string

William B Kannel

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Presentation of multivariate data for clinical use: The Framingham Study risk score functions.

Prediction of first coronary events with the Framingham score: a systematic review.

Thyroid status, cardiovascular risk, and mortality in older adults.

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.

P304

739-745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(09)60443-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

9665

http://www.w3.org/2001/XMLSchema#string

P478

373

http://www.w3.org/2001/XMLSchema#string

P50

Christopher Newton-Cheh

Emelia J. Benjamin

Ramachandran S. Vasan

Lisa M Sullivan

Michael J Pencina

Joseph M Massaro

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19249635

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

2764235

http://www.w3.org/2001/XMLSchema#string